FDA Approvals in Oncology: January-March 2023
With the approval of new anticancer therapeutics, more treatment options become available for patients. Some therapies are new to...
Author:
Cancer Research Catalyst Staff
With the approval of new anticancer therapeutics, more treatment options become available for patients. Some therapies are new to...
The AACR Annual Meeting 2023 kicks off Friday, April 14, with thousands of cancer researchers from around the world...
As we welcome spring, enjoy the latest round of editors’ picks selected by the editors of AACR’s 10 journals....
As February gives way to March, we bring you the latest round of editors’ picks selected by the editors...
In the United States, about 40% of cancer cases are associated with preventable risk factors. According to the AACR...
Two years ago, amid increased awareness of the need to diversify the scientific work force and end cancer health...
Throughout his career as a cancer researcher, Robert A. Winn, MD, has seen a familiar pattern in progress. Each...
To kick off the new year, the editors of the 10 AACR journals highlighted two phase I clinical trials,...
Guest post by Hisham Hamadeh, PhD, and Shawn M. Sweeney, PhD Imagine a world where many of the decisions...
2023 is upon us, but before we dive into the new year, let’s look back at the featured articles...